Correction to: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

Ähnliche Einträge

• The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
  von: Gharebaghi, Naser, et al.
  Veröffentlicht: (2020)
• Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID‐19 in West Azerbaijan Province
  von: Gharebaghi, Naser, et al.
  Veröffentlicht: (2021)
• Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report
  von: Nejadrahim, Rahim, et al.
  Veröffentlicht: (2021)
• A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal.
  von: Ajit Rayamajhi, et al.
  Veröffentlicht: (2015-01-01)
• A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
  von: Rayamajhi, Ajit, et al.
  Veröffentlicht: (2015)